A nurse is providing teaching to the parent of a child who has a new prescription for methylphenidate. Which of the following instructions should the nurse include?

Choice A rationale Monitoring the child for excessive sleepiness is an incorrect instruction. Methylphenidate is a central nervous system stimulant and is used to treat ADHD. Its therapeutic effect is to increase attention span and decrease hyperactivity and impulsiveness. A common adverse effect is insomnia or difficulty sleeping, not excessive sleepiness. Therefore, monitoring for excessive sleepiness would not be an expected outcome. Choice B rationale Administering methylphenidate with a caffeinated beverage is contraindicated. Both caffeine and methylphenidate are stimulants. Combining them can lead to an exaggerated central nervous system stimulation, increasing the risk of adverse effects such as tachycardia, nervousness, anxiety, and hypertension. This combination can also increase the risk of cardiac arrhythmias and other cardiovascular complications. Choice C rationale Administering the second dose of the medication at lunchtime is the correct instruction. Methylphenidate has a short half-life, so a second dose is often necessary to provide therapeutic effects throughout the school day. Giving the second dose at lunchtime ensures the medication's effect lasts through the afternoon without interfering with the child's ability to fall asleep at night. Choice D rationale Monitoring the child for weight gain is an incorrect instruction. A common side effect of methylphenidate is appetite suppression and subsequent weight loss. The stimulant effect can decrease the child's desire to eat, leading to poor nutritional intake. Therefore, the nurse should instruct the parent to monitor for weight loss and ensure adequate nutrition, not weight gain.